Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects
Abstract This review examines the growing role of exosomes and circulating exosomal biomarkers in predicting response to immune checkpoint inhibitors (ICIs) in cancer therapy. While ICIs have revolutionized cancer treatment, predicting patient response remains a major challenge. Exosomes, small extr...
Saved in:
| Main Authors: | Can Lu, Muhammad Tufail, Can-Hua Jiang, Ning Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03806-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01) -
Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy
by: Xiangyu Yin, et al.
Published: (2024-11-01) -
Current Status of Immune Checkpoint Inhibitors and Treatment Responsive Biomarkers for Triple‐Negative Breast Cancer
by: Xinran Wang, et al.
Published: (2025-05-01) -
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01) -
Nanomaterials and immune checkpoint inhibitors in cancer immunotherapy: the synergistic innovation prospects
by: Jing Chen, et al.
Published: (2025-06-01)